Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.41 USD | +1.26% | +22.96% | -19.93% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Financials (USD)
Sales 2024 * | 4.45M | Sales 2025 * | 1.27M | Capitalization | 133M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -92M | EV / Sales 2024 * | 1.34 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 30.93M | EV / Sales 2025 * | 80.2 x |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-1.99
x | Employees | 94 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.08% |
Latest transcript on Omega Therapeutics, Inc.
1 day | +1.26% | ||
1 week | +22.96% | ||
Current month | +8.07% | ||
1 month | -0.41% | ||
3 months | -43.82% | ||
6 months | +12.62% | ||
Current year | -19.93% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 22-05-22 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.41 | +1.26% | 272,038 |
24-05-16 | 2.38 | +4.39% | 195,264 |
24-05-15 | 2.28 | -3.39% | 414,185 |
24-05-14 | 2.36 | +0.21% | 426,960 |
24-05-13 | 2.355 | +20.15% | 742,178 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.93% | 133M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- OMGA Stock